Progress in Drug Research
-
- Hardcover
- Taschenbuch ausgewählt
-
Sprache:Englisch
-
Auflage:Softcover reprint of the original 1st ed. 1998
- Softcover reprint of the original 1st ed. 2003 195,99 €
- Softcover reprint of the original 1st ed. 1999 49,99 €
- Softcover reprint of the original 1st ed. 1998 49,99 € ausgewählt
- Softcover reprint of the original 1st ed. 1998 98,99 €
- Softcover reprint of the original 1st ed. 1997 51,99 €
- Softcover reprint of the original 1st ed. 1985 49,99 €
- Softcover reprint of the original 1st ed. 1989 49,99 €
- Softcover reprint of the original 1st ed. 2002 195,99 €
- Softcover reprint of the original 1st ed. 2002 195,99 €
- Softcover reprint of the original 1st ed. 2001 97,99 €
- Softcover reprint of the original 1st ed. 2000 49,99 €
- Softcover reprint of the original 1st ed. 2000 51,99 €
- 1. Auflage 95,99 €
49,99 €
inkl. gesetzl. MwSt.,
Lieferung nach Hause
Beschreibung
Produktdetails
Einband
Taschenbuch
Erscheinungsdatum
12.11.2011
Verlag
Springer BaselSeitenzahl
326
Maße (L/B/H)
24/17/1,9 cm
Gewicht
578 g
Auflage
Softcover reprint of the original 1st ed. 1998
Sprache
Englisch
ISBN
978-3-0348-9798-3
Due tothedevelopmentofdrugresistanceandotherlimitationsinthe treat ment of AIDS patients with reverse transcriptase (RT) inhibitors like zidovu dineandothers, itbecamenecessarytoexploreantiviralagentsactingontar getsotherthan RT. Inthepastfewyears, hundredsofHIVproteaseinhibitoLs have been synthesized and tested. Among these protease inhibitors, saquinavir, ritonavir, indinavir and nelfinavir have been marketed during 1995-1997. In this review, emphasis is placed on the development of HIV protease inhibitors as antiviral agents against HIV, structure-activity rela tionship (SAR) analysis ofsaquinavirand relatedcompounds, comparisonof four marketed HIV protease inhibitors, and future prospect in developing new anti-HIV drugs. 2 Introduction HIV protease inhibitors 3 HIV protease as a target for chemotherapy HIV protease was first suggested as a potential target for AIDS therapy by Kramer et a1. in 1986 [5]. HIV protease is a proteolytic enzyme responsible for cleaving large numbers of amino acid sequences. This enzyme regulates conversionoftheselargeaminoacid sequencesintobiologicallyactive struc tural and functional protein products. Specifically, HIV protease is responsi the enzymatic processing of the gagand gag-pol genes of HIV, which ble for encode for functional core proteins and viral enzymes (reverse transcriptase, ribonuclease H, integrase, and HIV protease). The polyproteins encoded by the gagand gag-pol genes undergo post-translational processing by HIV pro tease to form functional protein products as the viral particles budding out from infected cells. Therefore, inhibition of HIV protease by a protease inhibitor results in the release ofimmature, noninfectious viral particles [4].
Kundinnen und Kunden meinen
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kund*innen durch Ihre Meinung
Kurze Frage zu unserer Seite
Vielen Dank für dein Feedback
Wir nutzen dein Feedback, um unsere Produktseiten zu verbessern. Bitte habe Verständnis, dass wir dir keine Rückmeldung geben können. Falls du Kontakt mit uns aufnehmen möchtest, kannst du dich aber gerne an unseren Kund*innenservice wenden.
zum Kundenservice